* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download causes of heart failure
Remote ischemic conditioning wikipedia , lookup
Cardiovascular disease wikipedia , lookup
Lutembacher's syndrome wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Electrocardiography wikipedia , lookup
Jatene procedure wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Cardiac surgery wikipedia , lookup
Mitral insufficiency wikipedia , lookup
Heart failure wikipedia , lookup
Coronary artery disease wikipedia , lookup
Antihypertensive drug wikipedia , lookup
Heart arrhythmia wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
Dextro-Transposition of the great arteries wikipedia , lookup
CHRONIC HEART FAILURE Pathophysiology Toni M. Aprami Department of Cardiology and Vascular Medicine Cardiovascular Subdivision, Department of Internal Medicine Hasan Sadikin Hospital/Medical School, Padjadjaran University Pulmonary veins Definition : Heart Failure “The situation when the heart is incapable of maintaining a cardiac output adequate to accommodate metabolic requirements and the venous return.“ Braunwald’s Heart Disease, 8 Ed, 2008 th “Pathophysiological state in which an abnormality of cardiac function is responsible for the failure of the heart to pump blood at a rate commensurate with the requirements of the metabolizing tissues.” Euro Heart J; 2001. 22: 1527-1560 CAUSES OF HEART FAILURE Myocardial disease Viral or other infectious agents Coronary artery disease Toxic or drug-induced damage Myocardial infarction* Disorders of rate and rhythm Myocardial ischemia* Chronic bradiarrhythmias Chronic pressure overload Chronic tachyarrhythmias Hypertension* Pulmonary heart disease Obstructive valvular disease* Cor pulmonale Chronic volume overload Pulmonary vascular disorders Regurgitant valvular disease High-output state Intracardiac (left-to-right) shunting Metabolic disorders Extracardiac shunting Nonischemic dilated cardiomyopathy Familial/genetic disorders Thyrotoxicosis Nutritional disorders (beriberi) Excessive blood flow requirements Infiltrative disorders* Systemic arteriovenosus shunting Metabolic disorders* Chronic anemia *Indicates conditions that can also lead to HF with a preserved ejection fraction Block diagram of left ventricular pump performance PULMONARY VENOUS PRESSURE Input Filling ED volume Emptying x EFeffective Stroke volume x Heart rate = LV Distensibility Relaxation Left atrium Mitral valve Pericardium Contractility Afterload Preload Structure Diastolic function Systolic function Output (Little, 2001) CARDIAC OUTPUT Lung SVC Left atrium Pulmonal vein Pump Container Right Atrium Left ventricle Systemic Vascular Resistance (SVR) IVC Right ventricle organ Volume (blood within circulatory system) DETERMINANTS OF VENTRICULAR FUNCTION CONTRACTILITY PRELOAD AFTERLOAD STROKE VOLUME HEART RATE - Synergistic LV contraction - LV wall integrity - Valvular competence CARDIAC OUTPUT Determinants of heart rate: -balance of parasympathetic and sympathetic tone -sinus node function -presence of an ectopic focus -conduction system COMPENSATORY MECHANISM • Frank - Starling mechanism • Neurohormonal stimulation • Myocardial hypertrophy with or without chamber dilatation Myocardial Failure or Valvular Insufficiency Reduced cardiac output Reduced blood pressure Decreased tissue perfusion Activation of compensatory mechanisms: -Sympathetic Nervous System (SNS) -Frank-Starling Mechanism -Renin-Angiotensin-System (RAS) -Aldosterone -Ventricular hypertrophy -others… (anti-diuretic hormone, atrial natriuretic factor) An effort to normalize tissue perfusion and blood pressure Myocardial Failure or Valvular Insufficiency Activates Compensatory Mechanisms SNS Anti-diuretic Hormone RAS Angiotensin II Vasoconstriction Heart Rate Aldosterone Sodium and water retention Increased Venous Return and Increased Blood Pressure F-S Mech. Contractility Augmentation of cardiac performance CONCENTRIC HYPERTROPHY PRESSURE OVERLOAD Thickened Ventricular Walls Altered ventricular geometry Myocardial Failure Valvular Insufficiency Ischemia and Fibrosis Elevated Cardiac Filling Pressures Diastolic Dysfunction CONGESTIVE HEART FAILURE - Myocardial Failure - Valvular Insufficiency -Moderate to large L -> R shunt VOLUME OVERLOAD - Thick and Stiff Ventricular Walls - Abnormal Ventricular Relaxation - Ventricular Fibrosis -Pericardial Disease DIASTOLIC DYSFUNCTION Elevated Cardiac Filling Pressures CONGESTIVE HEART FAILURE MECHANISM OF HEART FAILURE Pressure Normal pumping function overload Volume Compensatory overload mechanism adequate failed Heart failure Myocardial contractility Classical Pathophysiology of HF Primary disease state Decreased aortic pressure Decreased cardiac output SNS stimulation Vasoconstriction Ventricular dilatation Heart Failure symptoms Release of Renin / angiotensin aldosteron Increased vascular volume Increased afterload Increased Preload MI-INDUCED HEART FAILURE Myocardial Damage Contractility Pump Performance Systolic Work Load Vasoconstriction RAAS SYSTEM FLUID RETENTION SAS Drive EVOLUTION OF CLINICAL STAGES Normal No symptoms Asymptomatic Normal exercise LV Dysfunction Normal LV fxn No symptoms Compensated Normal exercise CHF Abnormal LV fxn No symptoms Decompensated Exercise CHF Abnormal LV fxn Symptoms Refractory Exercise CHF Abnormal LV fxn Symptoms not controlled with treatment Stages in the evolution of HF and recommended therapy by stage Stage A Pts with : • Hypertension • CAD • DM • Cardiotoxins • FHx CM Stage B Struct. Heart Disease THERAPY • Treat Hypertension • Stop smoking • Treat lipid disorders • Encourage regular exercise • Stop alcohol & drug use • ACE inhibition Stage C Pts with : • Previous MI Develop • LV systolic dysfunction Symp.of • Asymptomatic HF Valvular disease THERAPY • All measures under stage A • ACE inhibitor • Beta-blockers Stage D Pts with : • Struct. HD • Shortness of breath and fatigue, reduce exercise tolerance Refract. Symp.of HF at rest THERAPY • All measures under stage A • Drugs for routine use: • diuretic • ACE inhibitor • Beta-blockers • digitalis Pts who have marked symptoms at rest despite maximal medical therapy. THERAPY • All measures under stage A,B and C • Mechanical assist device • Heart transplantation • Continuous IV inotrphic infusions for palliation ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult 2005 Pregnancy Arrhythmias (AF) Endocarditis Obesity Infections Hyperthyroidism Hypertension Physical activity Thromboembolism Dietary excess Diagnosis of C H F IDENTIFICATIONS OF HEART FAILURE PATIENTS Criteria 1 and 2 should be fulfilled in all cases 1. Symptoms of heart failure (at rest or during exercise) And 2. Objective evidence of cardiac dysfunction (at rest) And (in cases where the diagnosis is in doubt) 3. Response to treatment directed towards heart failure Task Force Report. Guidelines for the diagnosis and treatment of chronic heart failure. European Society of Cardiology.2005 SYMPTOMS AND SIGN Breathlessness, Ankle Swelling, Fatique → Characteristic Symptoms Peripheral Oedema, JVP ↑, Hepatomegaly → Signs of Congestion of Systemic Veins S3 , Pulmonary Rales , Cardiac Murmur Physical Examinations of Heart Failure patient Vital Signs Abdominal • Positional blood pressure • Ascites • Pulse rate, rhythm, pulse pressure • Respiratory rate and pattern • Temperature • Hepatosplenomegaly • Pulsatile liver • Decreased bowel sounds • Obesity Neurologic • Mental status abnormalities Pulmonary Cardiovascular • Rales • Neck vein distention • Rhonchi • Prolonged expiration • wheezes • dullness to chest percussion • Friction rubs • Abdominal-jugular neck vein reflux • Cardiomegaly • Displaced, sustained, or hyperkinetic apical impulse • Chest wall pulsatile activity (Right ventricular lift) • Gallop rhythms • Heart murmurs (especially aortic, mitral, tricuspid, and pulmonic insufficiency or stenosis murmurs) • Diminished S1 or S2 • Friction rub • Peripheral venous insufficiency Systemic • Acrocyanosis • Edema • Temporal muscle wasting • Cachexia CHEST X-RAY A Part of Initial Diagnosis of HF → Cardiomegaly, Pulmonary Congestion, pulmonary disease In pts CHF, CTR > 0.50 and pulmonary congestion → indicators of abnormal cardiac func. with ↓ EF Relationship Between Radiological Signs and Haemodynamic Findings may Depend on the Duration and Severity HF ECG A normal ECG suggests that the diagnosis of CHF should be carefully reviewed LAH and LVH May Be Associated wit LV Dysfunction Anterior Q-wave and LBBB a good predictors of EF ↓↓ Detecting Arrhytmias as Causative of HF Value of electrocardiography* in identifying heart failure Resulting from left ventricular systolic dysfunction Sensitivity Specificity Positive predictive value Negative predictive value 94% 61% 35% 98% *Electrocardiographic abnormalities are defined as atrial fibrillation, evidence of Previous myocardial infarction, left ventricular hypertrophy, bundle branch block, and left axis deviation. HAEMATOLOGY & BIOCHEMISTRY A Part of Routine Diagnostic Hb, Leucocyte, Platelets Electrolytes, Creatinine, Glucose, Hepatic Enzyme, Urinalysis TSH, hs-CRP, Uric Acid ECHOCARDIOGRAPHY The Preferred Methods Helpful in Determining the Aetiology Follow Up of Patients Heart Failure NATRIURETIC PEPTIDES • Cardiac Function ↓↓ (LV Function ↓↓) → ↑↑ Plasma Natriuretic Peptide Concentration (Diagnostic Blood Use for HF) • Natriuretic Peptide ↑↑ : Greatest Risk of CV Events Natriuretic Peptide ↓↓ : Improve Outcome in Patients with Treatment • Identify Pts. With Asymptomatic LV Dysfunction (MI, CAD) PULMONARY FUNCTIONS A Little Value in Diagnosis Heart Failure Usefull in Excluding Respiratory Diseases EXERCISE TESTING Focused on Functional, Treatment Assessment and Prognostic STRESS ECHOCARDIOGRAPHY For Detecting Ischaemia Viability Study NUCLEAR CARDIOLOGY Not Recommended as a Routine Use CMR ( CARDIAC MAGNETIC RESONANCE IMAGING) Recommended if Other Imaging Techniques not Provided Diagnostic Answer INVASIVE INVESTIGATION Elucidating the Cause and Prognostic Informations – Coronary Angiography : in CAD’s Patients – Haemodynamic Monitoring : To Assess Diagnostic and Treatment of HF – Endomyocardial Biopsy : in Patients with Unexplained HF Terima Kasih